The study of apoptosis in endometrium of women with irregular uterine bleeding and its predictive value in endometrial malignancy. Analyze apoptotic and mitotic indices and their relevance in irregular uterine bleeding. To determine the expression of Bcl-2 oncoprotein in endometrial glands from patients with irregular uterine bleeding. Department of pathology in a Government Hospital serving a varied socio-economic population in Chennai. Random samples of endometrial currettings from dysfunctional uterine bleeding (DUB) patient who underwent endometrial curettage as therapeutic and diagnostic procedure during the year 2000. Of 50 cases of endometrial samples from patients diagnosed as cases of DUB, the apoptotic and mitotic indexing was carried out and histological categorization revealed 13 cases as Anovulatory. 14 as simple hyperplasia, 5 as early secretory endometrium, 4 as mid secretory and 4 as late secretory endometrium and 7 as endometrium showing features of hormonal imbalance. Three cases were not included, due to sub-optimal processing. A good correlation of the Bcl-2 expression and the apoptotic cell morphology/indices, in the different categories of the endometria of DUB cases is observed. This preliminary study gives an insight to the existence of a correlative pattern of apoptosis in DUB cases. A prospective study on a larger number of cases may substantiate the hypothesis that the Apoptotic and Mitotic indices are useful screening methods with predictive values on development of endometrial carcinoma. It is observed that an increased apoptotic index correlating with high Bcl-2 expression, reflecting the actual cell burden. This prolonged cell survival resisting cell deletion is associated with irregular uterine bleeding endometria.
We have investigated the characteristics of Brillouin-Erbium fiber laser (BEFL) with variation of Erbium-doped fiber amplifier (EDFA) locations in a ring cavity configuration. Three possible locations of the EDFA in the laser cavity have been studied. The experimental results show that the location of EDFA plays vital role in determining the output power and the tuning range. Besides the Erbium gain, Brillouin gain also contributes to the performance of the BEFL. By placing the EDFA next to the Brillouin gain medium (dispersion compensating fiber), the Brillouin pump signal is amplified thereby generating higher intensities of Brillouin Stokes line. This efficient process suppresses the free running self-lasing cavity modes from oscillating in cavity as a result of higher Stokes laser power and thus provide a wider tuning range. At the injected Brillouin pump power of 1.6 mW and the maximum 1480 nm pump power of 135 mW, the maximum Stokes laser power of 25.1 mW was measured and a tuning range of 50 nm without any self-lasing cavity modes was obtained.
The operation of a single-wavelength Brillouin-erbium fiber laser (BEFL) system with a Brillouin pump preamplified technique for different output coupling ratios in a ring cavity is experimentally demonstrated. The characteristics of Brillouin Stokes power and tunability were investigated in this research. The efficiency of the BEFL operation was obtained at an optimum output coupling ratio of 95%. By fixing the Brillouin pump wavelength at 1550 nm while its power was set at 1.6 mW and the 1480 pump power was set to its maximum value of 135 mW, the Brillioun Stokes power was found to be 28.7 mW. The Stokes signal can be tuned within a range of 60 nm from 1520 to 1580 nm without appearances of the self-lasing cavity modes in the laser system.